Cullinan Therapeutics, Inc.

NASDAQ:CGEM

Medical - Pharmaceuticals

Healthcare
$9.01 +4.29%

+$0.62 today

Market cap
$584.94M
Beta
0.01
P/E (TTM)
-4.0
EPS (TTM)
-$3.73
52W Low $5.68High $16.74

Volume 1.06M

Average 0.99M

Price history

Cullinan Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+6.63%

Period high

$22.95

Period low

$8.45

Latest

$9.01

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 10, 2026Nov 10, 2026
SC 13GNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
8-KNov 9, 2026Nov 9, 2026
4Nov 6, 2026Nov 6, 2026
8-KNov 4, 2026Nov 4, 2026
8-KOct 2, 2026Oct 1, 2026
8-KSep 24, 2026Sep 24, 2026
8-KSep 14, 2026Sep 14, 2026
4Sep 10, 2026Sep 10, 2026
4Aug 14, 2026Aug 14, 2026
SC 13GAug 14, 2026Aug 14, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
8-KAug 13, 2026Aug 12, 2026
SC 13GAug 7, 2026Aug 7, 2026

Competitors

Who does Cullinan Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CGEM's filings, answered from its disclosures.

What is the latest CGEM filing?

The latest filing shown is 10-Q dated Nov 10, 2026.

How many recent filings does CGEM have?

Intrinsic Alpha currently shows 20 recent filings for CGEM.